The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 03, 2026
Filed:
Mar. 06, 2019
Applicant:
Epibone, Inc., Long Island, NY (US);
Inventors:
Sarindr Bhumiratana, Oceanside, NY (US);
Terri-Ann Kelly, Springfield, MA (US);
Eric Meade Jeffries, Warrington, PA (US);
Olivia Spencer Beane, Rahway, NJ (US);
Angela Hai Huang, Flushing, NY (US);
Assignee:
EpiBone, Inc., Long Island, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/50 (2006.01); A61K 31/726 (2006.01); A61K 38/18 (2006.01); A61K 38/39 (2006.01); A61L 27/18 (2006.01); A61L 27/20 (2006.01); A61L 27/24 (2006.01); A61L 27/36 (2006.01); A61L 27/38 (2006.01); A61L 27/52 (2006.01); A61L 27/54 (2006.01); C12N 5/077 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0068 (2013.01); A61K 9/0019 (2013.01); A61K 9/06 (2013.01); A61K 9/5031 (2013.01); A61K 31/726 (2013.01); A61K 38/1841 (2013.01); A61K 38/39 (2013.01); A61L 27/18 (2013.01); A61L 27/20 (2013.01); A61L 27/24 (2013.01); A61L 27/3654 (2013.01); A61L 27/3662 (2013.01); A61L 27/3852 (2013.01); A61L 27/386 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); C12N 5/0655 (2013.01); C12N 5/066 (2013.01); A61L 2400/06 (2013.01); A61L 2430/06 (2013.01); A61L 2430/10 (2013.01); C12N 2501/15 (2013.01); C12N 2501/90 (2013.01); C12N 2501/998 (2013.01); C12N 2533/40 (2013.01);
Abstract
Compositions comprising a condensed mesenchymal cell body and a hydrogel are provided. The compositions may further include drugs or growth factors. The condensed mesenchymal cell body may include a connective tissue cell, or even a progenitor cell capable of producing connective tissue extracellular matrices such collagen and glycosaminoglycan. Also provided are methods of treating connective tissue defects, cartilage injury, and cartilage degradation.